bupropion and reserpine

bupropion has been researched along with reserpine in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.25)18.7374
1990's4 (25.00)18.2507
2000's6 (37.50)29.6817
2010's5 (31.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Buckett, WR; Frankland, AT; Gosden, J; Heal, DJ; Hutchins, LJ; Luscombe, GP; Prow, MR1
Minaian, A; Zarrindast, MR1
Colin, JN; Lacomblez, L; Martin, P; Massol, J; Puech, AJ1
Cooper, BR; Howard, JL; Soroko, FE1
Cooper, BR; Cox, RF; Ferris, RM; Norton, R; Shea, V; Wang, CM1
Gomita, Y; Nakagawa, T; Ohyama, T; Okamura, H; Ukai, K1
Morita, M; Umezu, T1
Bredeloux, P; Costentin, J; Dubuc, I1
Dhir, A; Kulkarni, SK1
Umezu, T1

Reviews

1 review(s) available for bupropion and reserpine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

15 other study(ies) available for bupropion and reserpine

ArticleYear
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2

    Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine.
    Psychopharmacology, 1992, Volume: 107, Issue:2-3

    Topics: Animals; Antidepressive Agents; Blepharoptosis; Brain Chemistry; Bupropion; Chromatography, High Pressure Liquid; Conditioning, Operant; Corpus Striatum; Cyclobutanes; Dopamine; Generalization, Psychological; Male; Methamphetamine; Rats; Reserpine; Stereotyped Behavior; Substantia Nigra

1992
Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
    General pharmacology, 1991, Volume: 22, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Bupropion; Dopamine Agents; Dopamine Antagonists; Ergolines; Injections, Subcutaneous; Male; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Swimming

1991
Antidepressant profile of bupropion and three metabolites in mice.
    Pharmacopsychiatry, 1990, Volume: 23, Issue:4

    Topics: Animals; Antidepressive Agents; Apomorphine; Body Temperature; Bupropion; Depression; Male; Mice; Motor Activity; Pimozide; Prazosin; Propiophenones; Propranolol; Reserpine; Yohimbine

1990
Animal models used in prediction of antidepressant effects in man.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:5 Pt 2

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depressive Disorder; Drug Evaluation, Preclinical; Drug Synergism; Helplessness, Learned; Humans; Levodopa; Mice; Models, Biological; Motor Activity; Propiophenones; Rats; Reserpine; Tetrabenazine

1983
Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1994, Volume: 11, Issue:2

    Topics: Animals; Behavior, Animal; Brain Chemistry; Bupropion; Dopamine; Electrophysiology; Female; In Vitro Techniques; Locus Coeruleus; Neurons; Norepinephrine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin; Substantia Nigra; Ventral Tegmental Area

1994
Effect of dopaminergic drugs on the reserpine-induced lowering of hippocampal theta wave frequency in rats.
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2000, Volume: 20, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Atropine; Bupropion; Cyclobutanes; Desipramine; Dopamine Agents; Dopamine Agonists; Hippocampus; Male; Methamphetamine; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Reserpine; Theta Rhythm

2000
Evidence for the involvement of dopamine in ambulation promoted by menthol in mice.
    Journal of pharmacological sciences, 2003, Volume: 91, Issue:2

    Topics: alpha-Methyltyrosine; Amphetamine; Animals; Bupropion; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Injections, Subcutaneous; Male; Menthol; Mice; Mice, Inbred ICR; Motor Activity; Reserpine; Stimulation, Chemical; Tyrosine 3-Monooxygenase

2003
Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.
    British journal of pharmacology, 2007, Volume: 150, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Bupropion; Corpus Striatum; Dextroamphetamine; Dopamine; Epilepsy, Generalized; Homovanillic Acid; Male; Mice; Motor Activity; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley; Reserpine; Synaptic Transmission

2007
Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    European journal of pharmacology, 2007, Jul-30, Volume: 568, Issue:1-3

    Topics: Animals; Antidepressive Agents, Second-Generation; Arginine; Behavior, Animal; Body Temperature; Brain; Bupropion; Cyclic GMP; Depression; Dopamine; Dopamine Uptake Inhibitors; Homovanillic Acid; Male; Mice; Motor Activity; Nitric Oxide; Norepinephrine; Rats; Rats, Wistar; Reserpine; Signal Transduction; Swimming

2007
Evidence for dopamine involvement in ambulation promoted by pulegone in mice.
    Pharmacology, biochemistry, and behavior, 2010, Volume: 94, Issue:4

    Topics: Animals; Bupropion; Cyclohexane Monoterpenes; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Interactions; Male; Mice; Mice, Inbred ICR; Monoterpenes; Reserpine; Walking

2010